AII
ALXN

AGF Investments Inc’s Alexion Pharmaceuticals ALXN Stock Holding History

AGF Investments Inc’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-146,323
Closed -$26.9M – 817
2021
Q2 		$26.9M Sell
146,323
-3,098
-2% -$532K 0.2% 136
2021
Q1 		$22.8M Sell
149,421
-166,776
-53% -$25.8M 0.18% 141
2020
Q4 		$49.4M Sell
316,197
-35,680
-10% -$4.58M 0.42% 89
2020
Q3 		$40.3M Buy
351,877
+5,661
+2% +$611K 0.4% 84
2020
Q2 		$38.9M Buy
346,216
+9,624
+3% +$1.02M 0.41% 92
2020
Q1 		$30.2M Buy
336,592
+310,051
+1,168% +$30.4M 0.37% 92
2019
Q4 		$2.87M Buy
26,541
+19,802
+294% +$2.12M 0.03% 227
2019
Q3 		$660K Buy
6,739
+1,418
+27% +$160K 0.01% 303
2019
Q2 		$697K Buy
5,321
+245
+5% +$31.6K 0.01% 302
2019
Q1 		$686K Buy
5,076
+524
+12% +$65.2K 0.01% 311
2018
Q4 		$443K Buy
+4,552
New +$538K 0.01% 339

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

AGF Investments Inc's ALXN Position: Q3 2021 in Review

AGF Investments Inc sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 146,323 shares — an estimated $26.9M sold.

AGF Investments Inc first reported a position in ALXN in Q4 2018 and held it in 11 quarters. The position peaked at $49.4M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • AGF Investments Inc reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • AGF Investments Inc sold 146,323 Alexion Pharmaceuticals shares in Q3 2021, an estimated $26.9M.
  • AGF Investments Inc first reported a position in Alexion Pharmaceuticals in Q4 2018 and held it in 11 quarters.
  • AGF Investments Inc's Alexion Pharmaceuticals position peaked at $49.4M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on AGF Investments Inc's 13F filing for Q3 2021, filed 10 Nov 2021.